What Supplements Help With Atrial Fibrillation?

Evidence-based review of supplements for AFib, covering rhythm support, cardiac energy, and critical warnings about drug interactions.

Magnesium has the strongest evidence of any supplement for reducing atrial fibrillation risk, particularly around heart surgery, where meta-analyses show it can cut post-operative AF rates roughly in half. Beyond magnesium, a handful of other supplements show promise in smaller studies, including coenzyme Q10, vitamin C, and N-acetylcysteine. But the research picture is uneven, and some popular supplements marketed for heart health, most notably fish oil, appear to increase AF risk rather than lower it. If you have atrial fibrillation or are at risk for it, the supplement landscape is a mix of genuine potential and real hazards worth understanding before you buy anything.

Magnesium Has the Most Evidence

Magnesium plays a direct role in heart rhythm stability. It helps regulate the electrical impulses that keep your heartbeat coordinated, and low magnesium levels are common in people with AF. The bulk of the research focuses on preventing AF after cardiac surgery, a setting where AF is extremely common and the stakes of prevention are high.

A 2025 systematic review and meta-analysis of randomized trials found that magnesium reduced the risk of new-onset post-operative AF by about 30% in the higher-quality trials analyzed. An earlier meta-analysis found that magnesium dropped post-operative AF rates from about 28% in untreated patients to about 18% in those who received it. Most of these studies used intravenous magnesium in a hospital setting, not oral supplements taken at home.

The evidence for oral magnesium supplements in everyday AF management is thinner. A pilot randomized trial tested oral magnesium in people with supraventricular arrhythmias and found that supplementation raised serum magnesium levels over 12 weeks, but the trial was too small to draw firm conclusions about whether episodes of arrhythmia decreased. Still, given that many people are mildly deficient in magnesium and that the mineral has a strong safety profile at normal supplemental doses, correcting a deficiency is a reasonable step to discuss with your doctor.

Coenzyme Q10 Shows Early Promise

Coenzyme Q10 (CoQ10) is an antioxidant your body produces naturally, and its levels tend to decline with age and with the use of statins. A small study of patients with heart failure found that those who took CoQ10 for 12 months developed AF at a much lower rate than controls: roughly 6% compared to 22%. A meta-analysis pooling five randomized controlled trials of CoQ10 around cardiac surgery found that it reduced post-operative AF by about 45%.

These results are encouraging, but the total number of patients studied remains small. CoQ10 is well tolerated by most people and has few side effects at typical supplement doses, which is part of why researchers keep returning to it. Larger trials are needed before anyone can say with confidence that it prevents AF.

Vitamin C Around Cardioversion

Vitamin C is another antioxidant that has been tested in AF, with results that depend heavily on the context. One Greek trial found that patients who took oral vitamin C after electrical cardioversion had a dramatically lower rate of AF recurrence within one week: about 5% compared to 36% in the control group. A systematic review confirmed that the single cardioversion trial showed a large reduction in recurrence risk.

But when vitamin C was tested in a different context, catheter ablation for AF, a randomized double-blinded pilot study found no significant differences in pain levels or early AF recurrence between the vitamin C group and placebo. The cardioversion finding is intriguing but based on a single small trial, so treating vitamin C as a proven AF therapy would be premature.

N-Acetylcysteine Has Mixed Results

N-acetylcysteine (NAC) is an antioxidant compound perhaps best known as the hospital treatment for acetaminophen overdose. Oxidative stress is implicated in the development of AF, so the logic of testing an antioxidant like NAC makes sense. A pilot study found that NAC reduced post-operative AF from about 21% to 5%. A meta-analysis of eight randomized controlled trials found an overall significant reduction in post-operative AF with NAC.

However, a separate double-blinded trial using high-dose oral NAC found no significant difference in AF rates between the supplement and placebo groups. The inconsistency across studies might relate to dosing, timing, or the route of administration (intravenous versus oral). Like many supplements on this list, NAC has enough biological plausibility and positive signals that it warrants larger, well-designed trials, but not enough to recommend it specifically for AF prevention.

Fish Oil Can Actually Increase AF Risk

This is the finding that catches most people off guard. Omega-3 fatty acid supplements, commonly sold as fish oil, are widely taken for heart health. But several large studies have now linked regular fish oil use with a higher risk of developing atrial fibrillation. A large prospective study using UK Biobank data found that among people without existing cardiovascular disease, regular fish oil supplement use was associated with a 13% increased risk of transitioning to AF.

This is not an isolated finding. A review of the clinical trial literature noted that while some trials have shown cardiovascular benefits from omega-3 fatty acids, others have found an increased risk of AF specifically. The risk appears to be dose-dependent, with higher-dose prescription omega-3 products carrying a greater AF signal than standard over-the-counter fish oil capsules. If you already have AF or are at elevated risk, this is worth discussing with your cardiologist before continuing or starting fish oil.

Vitamin D Deficiency Matters, but Supplementation Evidence Is Weak

Low vitamin D levels have been consistently linked to a higher risk of AF in observational studies. Research suggests that vitamin D deficiency promotes structural changes in the heart’s upper chambers, including increased scarring that creates the kind of electrical disorganization that sustains AF. A review described vitamin D as “an emerging risk factor” for AF based on its role in the underlying changes to heart tissue.

The problem is that the leap from “deficiency is associated with AF” to “supplementation prevents AF” has not been convincingly made. The Finnish Vitamin D Trial, a large randomized trial in generally healthy adults, acknowledged that while observational data link low vitamin D to higher AF risk, direct intervention evidence remains limited. If you are deficient in vitamin D, correcting that deficiency makes sense for many reasons, but expecting it to prevent AF episodes is not well supported by current trial data.

Potassium Supplementation Did Not Help in a Large Trial

Potassium is critical for heart rhythm, and low potassium is a known trigger for arrhythmias. It seems logical that keeping potassium levels high after heart surgery would prevent AF. But the TIGHT K randomized clinical trial, which compared aggressive potassium supplementation to a more relaxed approach after cardiac surgery, found no difference in AF rates. About 26% of patients in the tightly supplemented group developed AF, compared to about 28% in the relaxed group, a gap that was not statistically meaningful. The aggressive approach did, however, cost significantly more per patient.

This does not mean potassium is irrelevant to AF. Severely low potassium is still dangerous and needs correction. But the trial suggests that pushing potassium levels higher than necessary does not provide additional AF protection, at least in the surgical setting.

Zinc Deficiency and AF Risk

A large multi-institutional study found a clear connection between low serum zinc levels and the risk of developing AF. Severe zinc deficiency, with levels below 50 micrograms per deciliter, was associated with roughly double the risk of AF compared to people with normal zinc levels. Even mild-to-moderate zinc deficiency showed a modest but statistically significant increase in risk. As with vitamin D, this is observational data showing an association, not proof that taking zinc supplements will prevent AF. But it adds zinc status to the list of nutritional factors worth paying attention to.

What the Animal and Early Human Studies Are Exploring

Several supplements are generating interest in laboratory and animal research, though they have not been tested rigorously in humans with AF.

Curcumin, the active compound in turmeric, has reduced AF susceptibility in aging mice by decreasing inflammation and atrial scarring. Rat studies have shown it reduces the duration of AF episodes and decreases inflammatory markers in heart tissue. Curcumin is widely available as a supplement and generally safe, but its poor absorption in the gut has always been a limitation. Whether the doses that work in mouse hearts can produce meaningful effects in human hearts is unknown.

Taurine, an amino acid found in meat and fish, has been shown in rat models to shorten AF duration and prevent the electrical remodeling that makes AF self-sustaining. Human studies have found that taurine levels are elevated in people with paroxysmal AF, which researchers interpret as a compensatory response to the oxidative stress that AF causes. No clinical trial has tested taurine supplementation for AF in humans.

L-carnitine, a compound involved in energy production in cells, was tested in a small study of patients undergoing aortic valve surgery. The AF rate was 20% in the L-carnitine group compared to 60% in controls, a substantial difference despite the tiny sample size.

Probiotics are an emerging area of interest because of the growing recognition that gut bacteria influence heart health. A rat study found that probiotic treatment restored gut microbial diversity, increased production of short-chain fatty acids, and suppressed inflammatory pathways associated with AF. Separately, a long-term human cohort study found that specific gut bacterial genera were associated with both existing and future AF, suggesting that the gut-heart connection is real even if we do not yet know how to exploit it therapeutically.

Melatonin, best known as a sleep supplement, has antioxidant and anti-inflammatory properties that have drawn interest in cardiac research. A review described it as having antiarrhythmic potential, particularly in the context of age-related cardiac changes. Whether melatonin supplements affect AF risk or burden in humans has not been established in clinical trials.

Supplements That Can Trigger or Worsen AF

Not every supplement is neutral, and some can directly provoke AF episodes. Stimulant-containing supplements are the most obvious offenders. A case report described a 25-year-old man with no cardiac history who developed AF with a dangerously fast heart rate after taking over-the-counter stimulant capsules loaded with high doses of caffeine. Energy supplements, pre-workout formulas, and weight-loss products frequently contain stimulants that can push a susceptible heart into arrhythmia.

Creatine monohydrate, a common supplement among athletes, has been linked to AF in case reports. A 30-year-old man with no relevant medical history presented to the emergency department in AF with a rapid ventricular response; his only identifiable risk factor was creatine supplementation. Case reports cannot prove causation, but they are worth noting given how widely creatine is used.

Herbal products can also be problematic. A review of plants and herbal components with cardiac activity warned that some popular herbal remedies, including hawthorn, ginseng, and licorice, can amplify the rhythm-disturbing effects of standard cardiovascular drugs. A broader review in a cardiology journal concluded that some herbal supplements can cause serious pro-arrhythmic effects on their own and interact dangerously with drugs like warfarin and digoxin.

Anticoagulant Interactions Are a Serious Concern

Many people with AF take blood thinners to prevent stroke, and this is where supplement use gets genuinely dangerous. A systematic review identified 78 herbs, foods, or dietary supplements that interact with warfarin. More than half of those interactions strengthened warfarin’s blood-thinning effect, raising the risk of bleeding. Twenty of the supplements were linked to actual bleeding events, including cases of intracranial hemorrhage.

Some specific interactions are well documented. Ginger, even in small amounts, and mango can both strengthen warfarin’s effect. St. John’s wort does the opposite, reducing warfarin’s effectiveness and raising the risk of clots. Patients on warfarin also need to be cautious with green leafy vegetables high in vitamin K, which can counteract the drug, though the advice is to keep intake consistent rather than avoid these foods entirely.

The newer direct oral anticoagulants have fewer known food and supplement interactions than warfarin, but as one review pointed out, that is partly because they have not been on the market as long and interactions are still being discovered. If you take any blood thinner for AF, you should tell your prescriber about every supplement you use, including ones that seem harmless. The interaction risk is not theoretical: it can mean the difference between effective stroke prevention and a life-threatening bleed.

Why No Major Guideline Recommends Supplements for AF

The 2023 joint guideline from the American College of Cardiology, American Heart Association, and the Heart Rhythm Society provides comprehensive recommendations for diagnosing and managing AF, and supplements do not appear among the endorsed treatments. This is not because the research is being ignored. It reflects the fact that most supplement studies in AF are small, use surrogate endpoints, focus on surgical patients, or are limited to animal models. The bar for a clinical recommendation is high, and no supplement has cleared it.

That does not mean supplements are useless. Correcting a genuine deficiency in magnesium, vitamin D, or zinc is good medical practice for many reasons, and doing so removes a potential contributor to arrhythmia risk. But treating supplements as a substitute for rate-control medications, rhythm-control drugs, catheter ablation, or anticoagulation therapy would be a mistake with real consequences. The most productive approach treats supplements as one piece of a conversation with your cardiologist, not as a standalone strategy.